JP2024517547A5 - - Google Patents

Info

Publication number
JP2024517547A5
JP2024517547A5 JP2023555343A JP2023555343A JP2024517547A5 JP 2024517547 A5 JP2024517547 A5 JP 2024517547A5 JP 2023555343 A JP2023555343 A JP 2023555343A JP 2023555343 A JP2023555343 A JP 2023555343A JP 2024517547 A5 JP2024517547 A5 JP 2024517547A5
Authority
JP
Japan
Prior art keywords
reuteri
dsm
strain
reuteri strain
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517547A (ja
Filing date
Publication date
Priority claimed from EP21162451.5A external-priority patent/EP4056053A1/en
Application filed filed Critical
Publication of JP2024517547A publication Critical patent/JP2024517547A/ja
Publication of JP2024517547A5 publication Critical patent/JP2024517547A5/ja
Pending legal-status Critical Current

Links

JP2023555343A 2021-03-12 2022-03-11 L.ロイテリ(l.reuteri)のプレコンディショニング Pending JP2024517547A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21162451.5 2021-03-12
EP21162451.5A EP4056053A1 (en) 2021-03-12 2021-03-12 Pre-conditioning of l. reuteri
PCT/SE2022/050247 WO2022191768A1 (en) 2021-03-12 2022-03-11 Pre-conditioning of l.reuteri

Publications (2)

Publication Number Publication Date
JP2024517547A JP2024517547A (ja) 2024-04-23
JP2024517547A5 true JP2024517547A5 (https=) 2025-03-06

Family

ID=74873672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555343A Pending JP2024517547A (ja) 2021-03-12 2022-03-11 L.ロイテリ(l.reuteri)のプレコンディショニング

Country Status (7)

Country Link
US (1) US20230227771A1 (https=)
EP (2) EP4056053A1 (https=)
JP (1) JP2024517547A (https=)
CN (1) CN117177673A (https=)
CA (1) CA3205981A1 (https=)
MX (1) MX2023009965A (https=)
WO (1) WO2022191768A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116333910B (zh) * 2022-09-23 2024-09-20 华中农业大学 一种促进罗伊氏乳杆菌生长的培养基及方法
WO2025078557A1 (en) * 2023-10-11 2025-04-17 Société des Produits Nestlé S.A. Compositions comprising a probiotic strain for improving muscle strength

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2688538T3 (es) 2010-12-23 2018-11-05 Dupont Nutrition Biosciences Aps Composiciones crioprotectoras y uso de las mismas
EP2677886A4 (en) * 2011-02-23 2015-09-02 Biogaia Ab INDIRECT SUBSTRATES FOR MICRO-ORGANISMS FOR THE METABOLIZATION OF 1,2-PROPANDIOL
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
EP3016511B1 (en) 2013-07-02 2019-10-09 Austrianova Singapore Pte Ltd. A method of freeze-drying encapsulated cells, compositions suitable for freezing of encapsulated cells and use of such compositions
GB201319531D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
GB201319539D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
EP3125905A4 (en) * 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
ES2870425T3 (es) * 2014-10-29 2021-10-27 Biogaia Ab Uso de L. reuteri para la prevención o el tratamiento de la disbiosis de microbiota en la vida temprana
WO2016113363A1 (en) * 2015-01-14 2016-07-21 Infant Bacterial Therapeutics Ab A method of activating lactic acid bacteria
WO2017001590A1 (en) 2015-06-30 2017-01-05 Nestec S.A. Composition suitable for protecting microorganisms
MX2019014315A (es) * 2017-08-04 2020-02-03 Nestle Sa Bacterias probioticas preacondicionadas en un medio que contiene gos y uso de estas.
AU2020218748B2 (en) * 2019-02-05 2023-12-21 Biomedit, Llc A genetically modified lactobacillus and uses thereof

Similar Documents

Publication Publication Date Title
Chiang et al. Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products
JP2024517546A5 (https=)
NL2004200C2 (en) Use of sialyl oligosaccharides in weight management.
JP6479768B2 (ja) 新規ラクトバチラス・パラカゼイ株
RU2011138363A (ru) Выделение, идентификация и характеристика штаммов с пробиотической активностью, выделенных из фекалий детей, вскармливаемых исключительно материнским молоком
WO2009151331A1 (en) Immune system stimulating nutrition
WO2010143940A1 (en) Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN111479579A (zh) 以双歧杆菌属细菌作为有效成分的组合物
JP2024517547A5 (https=)
JP7534870B2 (ja) 腸管発達促進用組成物、および腸疾患の予防、治療または症状軽減用組成物
WO2021235486A1 (ja) 腸管発達促進用組成物、肺機能改善用組成物および免疫機能向上用組成物
TW201105252A (en) Prevention and treatment of allergic diarrhoea
JP6491422B2 (ja) 免疫疾患予防剤
AU2006215205B2 (en) Composition for immunostimulation
JP2018177703A (ja) Toll様受容体2活性化用組成物
JP6821643B2 (ja) 免疫疾患予防剤
TW201701891A (zh) 大腸炎抑制劑
JP5836928B2 (ja) 大腸におけるビフィズス菌の増加及び減少抑制剤
US20230227771A1 (en) Pre-conditioning of l.reuteri
JP7533830B2 (ja) 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物
Desai et al. A revitalising approach towards aging: Unveiling the potential use of probiotics for wellness in elderly populations
JP7766703B2 (ja) トレオン酸含有組成物及びその製造方法
Desai et al. of Probiotics for Wellness in Elderly Populations
WO2022215568A1 (ja) 筋合成促進剤及びp70S6Kタンパク質のリン酸化促進剤
CN122003242A (zh) 用于保护紧密连接的组合物